You are here:
Home >
Investors

Investors Homepage

IR video blog May 1

Nestlé IR head Roddy Child-Villiers on Q1, 2012

Pfizer acquisition in 3 minutes

Watch the animated presentation for the Pfizer acquisition (three minutes)

Pfizer Nutrition acquisition

Strategic move to enhance our position in global infant nutrition. Listen to the audio webcast.

First quarter sales 2012

Q1 2012 sales were CHF 21.4bn (7.2% organic growth). Full-year outlook confirmed. Full details and conference call in Events

IR video commentary

This is the first in an occasional series of video commentaries from the Nestlé Investor Relations department, introduced by the head of IR, Roddy Child-Villiers

2011 Annual Report

On March 14 we published our 2011 Annual Report; access it from here to see our financials, the review of 2011 business and the outlook for 2012.

2011 in 3 minutes

Watch a short animation of a round-up of Nestlé in 2011, condensed to three minutes

CEO Paul Bulcke with CFO Wan Ling Martello (as of Apruil 1)

2011 Full Year Results

On February 16 2012 we published our 2011 full year results. This was accompanied by a packed agenda - see our events pages for full details.

2011 London roadshow

On February 21 2012 we held our Full Year Results roadshow at the London Stock Exchange

IR video blog May 1
Pfizer acquisition in 3 minutes
Pfizer Nutrition acquisition
First quarter sales 2012
IR video commentary
2011 Annual Report
2011 in 3 minutes
2011 Full Year Results
2011 London roadshow

Nestlé is the world's leading nutrition, health and wellness company. It is also our objective to be recognised as the industry reference for financial performance, and to deliver the Nestlé model: 5%-6% organic growth, improved trading operating profit margin and underlying earnings per share in constant currencies.